Harvard technology to be commercialized by Vesigen Therapeutics

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.

Caroline Perry • harvard
July 22, 2020 • ~10 min

E-cigarette flavorings may damage cilia production and function

A new study finds two chemicals commonly used to flavor e-cigarettes may be damaging cilia production and function in the human airway.

Karen Feldscher • harvard
Feb. 1, 2019 • ~4 min

/

1